Jenson Funding Partners backed the London-based online dermatology service to support platform development and service expansion.
"Without the ability to quickly and easily see a dermatologist, patients often go for months or even years without receiving proper treatment for acne, which can have a huge impact on emotional and mental health as well as the risk of causing permanent scarring. Typically, their treatment journey begins with online research, with resources varying in reliability, before trialling over-the-counter skincare products, which are not sufficient in a lot of cases,"
Maven Capital Partners backed the Manchester-based identity and access management platform to fund acquisitions and technical growth.
"Our partnership with Maven is a major milestone for ProofID. This investment gives us the platform to add new services and vendor partnerships to our portfolio to better serve our customers. We are excited about the prospect of working with the team at Maven to grow and develop our business over the coming years."
The syndicate included Mark Bamforth, Tern Plc, SIS Ventures, and Scottish Enterprise.
"2022 promises to be a big year for Talking Medicines with this new investment. Having scaled up our operations and formally launched our PatientMetrx® technology platform, we’ve now got our sights set on expanding in the US pharma market, providing brand teams and agencies with a new way of understanding what patients are really saying and feeling about their medicines. The pharmaceutical industry will go through seismic change this year and our actionable patient insights will be transformational for the industry. Our new office in New Jersey provides the ideal base for us to build relationships with customers, acquire new leads and drive revenue growth."
The company doubled its initial target with backing from Dymond Group and a European real estate operator.
"The opening of Air-One is a momentous occasion – the starting gun for a new age of transport, an age of zero-emission, low-congestion travel between and within cities that will make people healthier, happier and more connected than ever before,"
Octopus Ventures led the round as Contingent looks to scale its supply chain risk and transparency software.
"There is an ever-increasing amount of focus on risk management within supply chains and Contingent provides us with a platform to capture the key areas of risk. As we put more of a spotlight on ESG, the team at Contingent is continuously improving the platform, its features and coverage, which supports us as we continue to grow as a business,"
.png)